Inmune Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Inmune Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2020 to Q3 2024.
  • Inmune Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.72M, a 9% decline year-over-year.
  • Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.37M, a 3.06% increase from 2022.
  • Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.15M, a 49.1% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.72M -$170K -9% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $2.35M +$487K +26.1% Jun 30, 2024 10-Q 2024-08-01
Q4 2023 $1.92M Dec 31, 2023 10-K 2024-03-28
Q3 2023 $1.89M Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.86M Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.7M +$200K +13.3% Mar 31, 2023 10-Q 2023-05-03
Q1 2022 $1.5M +$600K +66.7% Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $900K Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2.76M Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.